Notice of NMPA on Matters Related to Further Strengthening the Administration of Radioactive Drugs (2022 No. 5)

Home News Insights

Database

Regulatory Database

Drug Catalog ChP Standards

Events

Webinars Offline Events

Services

Notice of NMPA on Matters Related to Further Strengthening the Administration of Radioactive Drugs (2022 No. 5)

Local Title:国家药监局关于进一步加强放射性药品管理有关事宜的通告（2022年第5号）
Country/Region:Chinese Mainland
Competent Authority: National Medical Products Administration (NMPA)
Type:Notice
Status:In force
Release Date:2022-01-14
Implementation Date:2022-01-14

Request

Document

Language	Source	Title	Access
ZH	Official	国家药监局关于进一步加强放射性药品管理有关事宜的通告（2022年第5号）	Download

Summary

The Notice of NMPA on Matters Related to Further Strengthening the Administration of Radioactive Drugs (2022 No. 5) was issued on Jan.14, 2022. It aims to further strengthen the production management of radioactive drugs, to ensure the quality of radioactive drugs safe and effective, which includes relevant policies, regulations, and measures.